Furthermore, HER2-CAR-M administered locally in these tumors inhibited the growth of contralateral HER2− tumors while also preventing antigen-negative relapse upon HER2− tumor rechallenge, indicating epitope spreading and the induction of long-term immune memory [405]. Here, ERBB2 is linked to neoplasm.